Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method

Archives of Pharmacal Research

Volumn 33, Issue 12, 2010, Pages 1967-1973

  Li, Feng Qian ^a   Ji, Rui Rui ^b   Chen, Xu ^a   You, Ben Ming ^b   Pan, Yong Hua ^b   Su, Jia Can ^b  

^a SHANGHAI EIGHTH PEOPLE'S HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cetirizine dihydrochloride; Chitosan; In vitro drug release; Ionotropic gelation; Nanoparticles in microparticles; Spray drying

Indexed keywords

CETIRIZINE; CHITOSAN; NANOPARTICLE; ORGANIC SOLVENT; TRIPOLYPHOSPHATE;

ARTICLE; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; GELATION; MICROENCAPSULATION; NANOENCAPSULATION; SPRAY DRYING;

ADMINISTRATION, ORAL; CETIRIZINE; CHITOSAN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; MICROSPHERES; NANOPARTICLES; PARTICLE SIZE; POLYPHOSPHATES; POWDERS; SOLUBILITY; TASTE PERCEPTION;

EID: 78751564475     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-1212-3     Document Type: Article

References (23)

1. A. K. Anal W. F. Stevens C. Remuòán-López 2006 Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin Int. J. Pharm. 312 166 173 1:CAS:528:DC%2BD28XisFeqsbc%3D 10.1016/j.ijpharm.2006.01.043 16497452
2. M. D. Bhavsar S. B. Tiwari M. M. Amiji 2006 Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design J. Control. Release 110 422 430 1:CAS:528:DC%2BD2MXhtlert7bO 10.1016/j.jconrel.2005.11.001 16338017
3. M. D. Bhavsar M. M. Amiji 2007 Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS) J. Control. Release 119 339 348 1:CAS:528:DC%2BD2sXlslSqu78%3D 10.1016/j.jconrel.2007.03.006 17475358
4. R. Bodmeier H. G. Chen O. Paeratakul 1989 A novel approach to the oral delivery of micro-or nanoparticles Pharm. Res. 6 413 417 1:CAS:528: DyaL1MXksVGiurg%3D 10.1023/A:1015987516796 2748533
5. R. Bodmeier K. H. Oh Y. Pramar 1989 Preparation and evaluation of drug-containing chitosan beads Drug Dev. Ind. Pharm. 15 1475 1494 1:CAS:528:DyaL1MXlt1Sku78%3D 10.3109/03639048909062758
6. R. Bodmeier H. Chen P. Tyle P. Jarosz 1991 Pseudophedrine HCl microspheres formulated into an oral suspension dosage form J. Control. Release 15 65 77 1:CAS:528:DyaK3MXhsFSju7k%3D 10.1016/0168-3659(91)90104-L
7. M. P. Curran L. J. Scott C. M. Perry 2004 Cetirizine: a review of its use in allergic disorders Drugs 64 523 561 1:CAS:528:DC%2BD2cXivFansbg%3D 10.2165/00003495-200464050-00008 14977391
8. A. A. Elzainy X. Gu F. E. Simons K. J. Simons 2005 Hydroxyzine- and cetirizine-loaded liposomes: effect of duration of thin film hydration, freeze-thawing, and changing buffer pH on encapsulation and stability Drug Dev. Ind. Pharm. 31 281 291 1:CAS:528:DC%2BD2MXjsVaqtL4%3D 15830724
9. F. W. Fraunfelder F. T. Fraunfelder 2004 Oculogyric crisis in patients taking cetirizine Am. J. Ophthalmol. 137 355 357 10.1016/S0002-9394(03)00869-9 14962433
10. F. Horak J. Toth B. Marks U. P. Stübner U. E. Berger S. Jäger B. Burtin C. Duby 1998 Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion Allergy 53 849 856 1:CAS:528:DyaK1cXmvVWks7g%3D 10.1111/j.1398-9995.1998.tb03990.x 9788685
11. D. Kalogeromitros C. Papageorgiou S. Gregoriou N. Chatziantonakis M. Makris N. Spanoudaki A. Rabavilas D. Rigopoulos T. C. Theoharides 2007 Depressive symptoms in urticaria patients treated with first-or second-generation histamine 1 receptor antagonists J. Clin. Psychopharmacol. 27 404 406 10.1097/01.jcp.0000264994.24148.d7 17632232
12. A. Kantar J. P. Rihoux R. Fiorini 1996 Effect of cetirizine on plasma membrane of human eosinophils, neutrophils and platelets: a dose response study Eur. J. Pharm. Sci. 4 101 107 1:CAS:528:DyaK28XhvVKltrk%3D 10.1016/0928-0987(95) 00037-2
13. F. Q. Li J. H. Hu B. Lu H. Yao W. G. Zhang 2001 Ciprofloxacin-loaded bovine serum albumin microspheres: preparation and drug-release in vitro J. Microencapsul. 18 825 829 1:CAS:528:DC%2BD3MXotVKit7o%3D 10.1080/ 02652040110055298 11695645
14. F. Q. Li J. H. Hu J. X. Deng H. Su S. Xu J. Y. Liu 2006 In vitro controlled release of sodium ferulate from Compritol 888 ATO based matrix tablets Int. J. Pharm. 324 152 157 1:CAS:528:DC%2BD28XhtVOgu7%2FN 10.1016/j.ijpharm.2006.06.006 16837152
15. F. Q. Li H. Su J. Wang J. Y. Liu Q. G. Zhu Y. B. Fei Y. H. Pan J. H. Hu 2008 Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting Int. J. Pharm. 349 274 282 1:CAS:528:DC%2BD1cXhtFCgsA%3D%3D 10.1016/j.ijpharm.2007.08.001 17870261
16. F. Q. Li H. Su X. Chen X. J. Qin J. Y. Liu Q. G. Zhu J. H. Hu 2009 Mannose 6-phosphate modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis J. Pharm. Pharmacol. 61 1155 1161 1:CAS:528:DC%2BD1MXhtFOgsLnJ 10.1211/jpp.61.09. 0004 19703364
17. G. Plember van Balen G. Caron G. Ermondi A. Pagliara T. Grandi G. Bouchard R. Fruttero P. A. Carrupt B. Testa 2001 Lipophilicity behaviour of the zwitterionic antihistamine cetirizine in phosphatidylcholine liposomes/water systems Pharm. Res. 18 694 701 1:STN:280:DC%2BD38%2Fit1ehsw%3D%3D 10.1023/A:1011049830615 11465428
18. X. Z. Shu K. J. Zhu 2000 A novel approach to prepare tripolyphosphate/ chitosan complex beads for controlled release drug delivery Int. J. Pharm. 201 51 58 1:CAS:528:DC%2BD3cXktFems7c%3D 10.1016/S0378-5173(00)00403-8 10867264
19. F. E. Simons 1990 Recent advances in HI-receptor antagonist treatment J. Allergy Clin. Immunol. 86 995 999 1:STN:280:DyaK3M%2Fos1Kmtg%3D%3D 10.1016/S0091-6749(05)80242-8 1979802
20. A. M. Ter Laak R. S. Tsai G. M. Donné-Op den Kelder P. A. Carrupt B. Testa H. Timmerman 1994 Lipophilicity and hydrogen-bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects Eur. J. Pharm. Sci. 2 373 384 10.1016/0928-0987(94)00065-4
21. A. Vila A. Sánchez K. Janes I. Behrens T. Kissel J. L. Vila Jato M. J. Alonso 2004 Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice Eur. J. Pharm. Biopharm. 57 123 131 1:CAS:528:DC%2BD2cXjsFakuw%3D%3D 10.1016/j.ejpb.2003.09.006 14729088
22. L. P. Zhao D. Y. Cao X. P. Feng L. H. Yuan 2004 Preparation of inclusion complex of cetirizine -β- cyclodextrin West China J. Pharm. Sci. 19 30 32
23. T. Zuberbier B. M. Henz 1999 Use of cetirizine in dermatologic disorders Ann. Allergy Asthma Immunol. 83 476 480 1:CAS:528:DyaK1MXotV2iu70%3D 10.1016/S1081-1206(10)62854-2 10582734